Table 2 |
|||
|
Relative sequence specificities of matrixins influenced by the P1' position |
|||
|
Relative rate of hydrolysis |
|||
|
|
|||
|
P4–P3–P2–P1 ~ P1'-P2'-P3'-P4' |
MMP-1 |
MMP-2 |
MMP-3 |
|
|
|||
|
Gly-Pro-Gln-Gly ~ Ile-Ala-Gly-Gln |
100 |
100 |
100 |
|
Gly-Pro-Gln-Gly ~ Leu-Ala-Gly-Gln |
130 |
88 |
110 |
|
Gly-Pro-Gln-Gly ~ Val-Ala-Gly-Gln |
9.1 |
30 |
53 |
|
Gly-Pro-Gln-Gly ~ Ser-Ala-Gly-Gln |
5.9 |
15 |
45 |
|
Gly-Pro-Gln-Gly ~ Phe-Ala-Gly-Gln |
20 |
55 |
140 |
|
Gly-Pro-Gln-Gly ~ Met-Ala-Gly-Gln |
110 |
230 |
60 |
|
Gly-Pro-Gln-Gly ~ Gln-Ala-Gly-Gln |
28 |
34 |
38 |
|
Gly-Pro-Gln-Gly ~ Glu-Ala-Gly-Gln |
<0.5 |
<0.5 |
<0.002 |
|
Gly-Pro-Gln-Gly ~ Arg-Ala-Gly-Gln |
<0.5 |
<0.5 |
<4.9 |
|
|
|||
|
MMP, matrix metalloproteinase. |
|||
|
Nagase and Brew Arthritis Res 2002 4(Suppl 3):S51 doi:10.1186/ar573 |
|||